NASDAQ:NXL Nexalin Technology (NXL) Stock Forecast, Price & News $0.47 +0.03 (+6.88%) (As of 09/26/2023 ET) Add Compare Share Share Today's Range$0.39▼$0.4750-Day Range$0.38▼$0.8352-Week Range$0.36▼$3.23Volume3,278 shsAverage Volume38,520 shsMarket Capitalization$3.46 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsFinancialsInsider TradesHeadlinesSEC FilingsShort InterestSocial MediaProfileChartCompetitorsEarningsFinancialsInsider TradesHeadlinesSEC FilingsShort InterestSocial Media About Nexalin Technology (NASDAQ:NXL) StockNexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. In addition, it designs and develops Generation 2 and Generation 3, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, Alzheimer's disease, and dementia. The company is based in Houston, Texas.Read More NXL Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NXL Stock News HeadlinesSeptember 14, 2023 | barrons.comNexalin Technology Inc.August 7, 2023 | finance.yahoo.comNexalin Technology Reports Results of Clinical Study Supporting the Therapeutic Benefits of its Gen-2, 15 Milliamp Neurostimulation Device in Treating Migraine Headaches and Related SymptomsSeptember 27, 2023 | Behind the Markets (Ad)66,000% upside on tiny biotech?The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.August 3, 2023 | finance.yahoo.comNexalin’s CEO Mark White to be Interviewed Live on “The Big Biz Show” Today at 3PM Eastern TimeJuly 27, 2023 | finance.yahoo.comNexalin Technology Announces New Public Sector Division to Capitalize on Opportunities to Serve U.S. Government AgenciesJuly 10, 2023 | finance.yahoo.comNexalin Technology Announces Abstract Accepted for Presentation at 2023 Military Health System Research Symposium Validating the Potential of its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device for the Treatment of Mild Traumatic Brain InjuryJune 1, 2023 | finance.yahoo.comNexalin Technology, Inc. and Wider Come Limited Announce Joint Venture Agreement to Advance Commercialization of Nexalin’s tACS Devices in the Asia Pacific RegionMarch 30, 2023 | finance.yahoo.comNexalin Technology Full Year 2022 Earnings: US$0.30 loss per share (vs US$1.43 loss in FY 2021)September 27, 2023 | Altimetry (Ad)Fraud Expert: Dump these three popular stocksA major (and legal) market manipulation scheme is about to play out. It could cost you a fortune – or double your money. You choose. Find out what he knows, here.March 27, 2023 | finanznachrichten.deNexalin Technology, Inc.: Nexalin Technology Provides 2022 Year-End Business UpdateMarch 27, 2023 | finance.yahoo.comNexalin Technology Provides 2022 Year-End Business UpdateJanuary 18, 2023 | seekingalpha.comNXL Nexalin Technology, Inc.January 5, 2023 | finance.yahoo.comNexalin Technology CEO Provides Letter to ShareholdersNovember 14, 2022 | finance.yahoo.comNexalin Technology Announces Publication of a White Paper Validating its tACS Device for the Treatment of Generalized Anxiety DisorderSeptember 26, 2022 | investing.comNexalin Technology Inc (NXL)See More Headlines Receive NXL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nexalin Technology and its competitors with MarketBeat's FREE daily newsletter. Email Address NXL Company Calendar Today9/26/2023Next Earnings (Estimated)9/27/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Electromedical equipment Sub-IndustryN/A SectorBusiness Services Current SymbolNASDAQ:NXL CUSIPN/A CIK1527352 Webwww.nexalin.com Phone832-260-0222FaxN/AEmployees6Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-1,700,000.00 Net Margins-374.88% Pretax Margin-371.49% Return on Equity-47.37% Return on Assets-36.22% Debt Debt-to-Equity RatioN/A Current Ratio4.32 Quick Ratio4.19 Sales & Book Value Annual Sales$649,847.00 Price / Sales5.33 Cash FlowN/A Price / Cash FlowN/A Book Value$0.75 per share Price / Book0.62Miscellaneous Outstanding Shares7,437,000Free FloatN/AMarket Cap$3.46 million OptionableNot Optionable BetaN/A 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Mark White (Age 61)Pres, CEO & Director Comp: $191.29kMs. Marilyn Elson (Age 69)Chief Financial Officer Comp: $356.73kDr. David Owens M.D. (Age 61)Chief Medical Officer & Director Mr. Michael Nketiah (Age 47)Sr. VP of Quality, Clinical & Regulatory Comp: $251.6kMr. John Patrick ClaudeCo-Founder and Director of Engineering & Devel.Mr. Joel BradusDirector of Sales & MarketingMore ExecutivesKey CompetitorsCuentasNASDAQ:CUENApplied UVNASDAQ:AUVIAgrifyNASDAQ:AGFYStaffing 360 SolutionsNASDAQ:STAFMedigusNASDAQ:MDGSView All CompetitorsInsidersMarilyn ElsonBought 9,500 shares on 9/28/2022Total: $10,640.00 ($1.12/share)View All Insider Transactions NXL Stock - Frequently Asked Questions How have NXL shares performed in 2023? Nexalin Technology's stock was trading at $0.7490 at the beginning of the year. Since then, NXL shares have decreased by 37.8% and is now trading at $0.4659. View the best growth stocks for 2023 here. Are investors shorting Nexalin Technology? Nexalin Technology saw a decrease in short interest in the month of August. As of August 31st, there was short interest totaling 11,100 shares, a decrease of 58.3% from the August 15th total of 26,600 shares. Based on an average trading volume of 27,300 shares, the short-interest ratio is presently 0.4 days. Approximately 0.2% of the company's shares are short sold. View Nexalin Technology's Short Interest. When is Nexalin Technology's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, September 27th 2023. View our NXL earnings forecast. When did Nexalin Technology IPO? (NXL) raised $10 million in an IPO on Friday, September 16th 2022. The company issued 2,315,000 shares at $4.15 per share. What is Nexalin Technology's stock symbol? Nexalin Technology trades on the NASDAQ under the ticker symbol "NXL." How do I buy shares of Nexalin Technology? Shares of NXL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Nexalin Technology's stock price today? One share of NXL stock can currently be purchased for approximately $0.47. How much money does Nexalin Technology make? Nexalin Technology (NASDAQ:NXL) has a market capitalization of $3.46 million and generates $649,847.00 in revenue each year. How can I contact Nexalin Technology? The official website for the company is www.nexalin.com. The company can be reached via phone at 832-260-0222 or via email at nxl@crescendo-ir.com. This page (NASDAQ:NXL) was last updated on 9/27/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nexalin Technology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.